INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 100 filers reported holding INARI MED INC in Q3 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,297,523 | -21.4% | 172,745 | -30.1% | 0.00% | -33.3% |
| Q2 2023 | $14,371,976 | -3.8% | 247,196 | +2.1% | 0.00% | 0.0% |
| Q1 2023 | $14,940,710 | +448.3% | 241,994 | +464.4% | 0.00% | – |
| Q4 2022 | $2,725,135 | -59.1% | 42,875 | -53.2% | 0.00% | -100.0% |
| Q3 2022 | $6,657,000 | -12.5% | 91,639 | -18.1% | 0.00% | 0.0% |
| Q2 2022 | $7,608,000 | -65.6% | 111,900 | -54.2% | 0.00% | -66.7% |
| Q1 2022 | $22,147,000 | -0.1% | 244,333 | +0.6% | 0.00% | +200.0% |
| Q4 2021 | $22,164,000 | +69.8% | 242,832 | +50.9% | 0.00% | -50.0% |
| Q3 2021 | $13,053,000 | +9.5% | 160,945 | +26.0% | 0.00% | 0.0% |
| Q2 2021 | $11,918,000 | -46.3% | 127,758 | -38.4% | 0.00% | -33.3% |
| Q1 2021 | $22,182,000 | +40.9% | 207,306 | +14.9% | 0.00% | +200.0% |
| Q4 2020 | $15,746,000 | +365.9% | 180,400 | +268.4% | 0.00% | – |
| Q3 2020 | $3,380,000 | – | 48,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |